Identifying And Mitigating Liabilities In Medical Device M&A

Medical device mergers and acquisition (M&A) transactions are accelerating as greater regulatory clarity develops and review times shorten in the U.S. Food and Drug Administration (FDA) regulatory process and the capital markets react positively to consolidation and new public offerings.  Additionally, private equity funds are participating in an increasing number of transactions involving firms with later stage or "mature" medical products.  While the medical device industry offers great opportunities, understanding and mitigating potential liabilities presented by device transactions is essential to manage investment losses.

Unique Liabilities Presented by Medical Device Companies